Sathgen Therapeutics announces dosing of the first patient cohort with MSP008-22, a novel anti-cancer drug

/PRNewswire/ -- Sathgen Therapeutics, a division of a leading chemicals conglomerate in India – Godavari Biorefineries Limited (GBL), has announced the...

Related Keywords

India ,Mumbai ,Maharashtra ,Sangeeta Srivastava ,Deepa Arora ,Sendurai Mani ,Samir Somaiya ,Godavari Biorefineries Limited ,Clinexel Life Sciences ,Legorreta Cancer Center ,Effect Of Chemotherapy During Preclinical Development ,Scientific Co ,Brown University ,Including Triple Negative Breast Cancer ,Enhanced Effect ,Sathgen Therapeutics ,New Chemical Entity ,Associate Director ,Scientific Co Founder ,Executive Director ,Executive Co Founder ,